Live Database

Opportunities
Search

Search the internal Cuberfy opportunities database for grants, startup programs, tenders, cloud credits and funding calls.

Searching the internal opportunities database and preparing the best matching records.
All Tenders Grants Funding Projects
45757 opportunities · Page 1520 of 1831
Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Eisen(III)natrium-Gluconat-Komplex (B03AC07) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Paliperidon (N05AX13) und dem Handelsnamen Trevicta® im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Dienogest und Estrogen (G03FA15) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Czechia – Forestry services – TĚŽEBNÍ ČINNOST BEZ HARVESTOROVÉ TECHNOLOGIE 2024
ted.europa.eu
Buyer: Vojenské lesy a statky ČR, s.p. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30
Tender Procurement Contract Czechia Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Vojenské lesy a statky ČR, s.p. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-09 - Golimumab
ted.europa.eu
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-10
ted.europa.eu
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Ireland – Financial management consultancy services – The Provision of Training Services for Local Enterprise Office Longford
ted.europa.eu
Buyer: Longford County Council_1128 | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-30
Tender Procurement Contract Ireland Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Longford County Council_1128 | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol (Wirkstoffkombination)
ted.europa.eu
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Febuxostat (ATC-Code nach WHO: M04AA03)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09...
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Fingolimod (ATC-Code nach WHO: L04AE01)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09...
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Telmisartan (ATC-Code nach WHO: C09CA07)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09...
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Latanoprost/Timolol (amtlicher ATC-Code: S01ED61)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09...
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30
TEN
Austria – Electrical wiring and fitting work – Errichtung von 100 MWp Photovoltaikanlagen
ted.europa.eu
Buyer: Energie Steiermark Green Power GmbH | Notice type: cn-standard | Procedure: neg-w-call | Contract: works | Deadline: 2026-09-30
Tender Procurement Contract Austria Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Energie Steiermark Green Power GmbH | Notice type: cn-standard | Procedure: neg-w-call | Contract: works | Deadline: 2026-09-30
TEN
Finland – Health services – Erikoislääkäripalvelut
ted.europa.eu
Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30
Tender Procurement Contract Finland Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30
TEN
Finland – Health services – Erikoislääkäripalvelut
ted.europa.eu
Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30
Tender Procurement Contract Finland Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30
GRA
Support European Food Bank Federation’s capacity building - 2026-2027
ec.europa.eu
Support European Food Bank Federation’s capacity building - 2026-2027
Grant Cash Grant Europe Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 30, 2026
Support European Food Bank Federation’s capacity building - 2026-2027
GRA
Advanced Technological Education
grants.gov
With a focus on two-year Institutions of Higher Education (IHEs), the Advanced Technological Education (ATE) program supports the education of technic...
Grant Cash Grant United States Open
AmountAward range: $475,000 - $7,500,000
DeadlineOct 1, 2026
With a focus on two-year Institutions of Higher Education (IHEs), the Advanced Technological Education (ATE) program supports the education of technicians for the high-technology fields that drive our nation's economy. The program involves partnerships between academic institutions (grades 7-12, IHEs), industry, and economic development agencies to promote improvement in the education of science and engineering technicians. It is strongly recommended that projects be faculty-led and required that courses and programs are credit-bearing, although materials developed may also be used for incumbent worker education. Materials may also be adapted and implemented as credit-bearing courses. The ATE program supports curriculum development; professional development of college faculty and secondary school teachers; career pathway development for both students and incumbent workers; and other activities including applied research projects that advance the knowledge base related to technician edu...
GRA
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
grants.gov
This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living huma...
Grant Cash Grant United States Open
AmountAward ceiling: $500,000
DeadlineOct 1, 2026
This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Both structural and functional aspects, including visualizing dynamic elements are important to development of new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Ultimately, research supported in response to this RFA is to encourage technologies that allow, for example, structures such as hair cells, otoliths, membranes, ions, and vasculature to be viewed in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multi-discipli...
GRA
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
grants.gov
This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and functional imaging te...
Grant Mixed United States Open
AmountAward ceiling: $500,000
DeadlineOct 1, 2026
This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Structural and functional aspects, including visualizing dynamic elements, are important to developing new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Research supported in response to this RFA is expected to significantly advance the ability to visualize auditory and vestibular components, such as hair cells, otoliths, membranes, ions, and vasculature, in detail in awake patients in a clinical setting using non-invasive techniques. To achi...
GRA
DoW, Ovarian Cancer, Investigator-Initiated Research Award
grants.gov
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2026
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care.Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials.Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering project should significantly advance the research beyond what would be possible through individual efforts.
GRA
DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award
grants.gov
Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing intensive mentoring, nati...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2026
Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the OCA is to conduct innovative and impactful ovarian cancer research while developing successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.Distinctive Features: The OCA is a virtual career development and research training platform that consists of Early-Career Investigators (ECIs), their Designated Mentors, and an Academy Dean and Assistant Dean. The OCA-ECI Award is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, Mentors, the Dean and Assistant Dean) as well as with the advocacy community.
GRA
DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award
grants.gov
Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clini...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2026
Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer.Distinctive Features: Research funded under this FY26 funding opportunity will support translational research and small-scale, early-phase clinical trials in ovarian cancer. Preliminary data are required, however, these data do not necessarily nee...
GRA
DoW Ovarian Cancer, Clinical Trial Award
grants.gov
Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the tre...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2026
Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.
GRA
DoW, Ovarian Cancer, Pilot Award
grants.gov
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, explori...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2026
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward.Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism.This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a collaborator, or the organization of the PI or collaborator.
GRA
EDU Core Research
grants.gov
The EDU Core Research (ECR) program offers this ECR:Core solicitation and invites proposals for fundamental research (curiosity-driven basic research...
Grant Cash Grant United States Open
AmountAward range: $500,000 - $2,500,000
DeadlineOct 1, 2026
The EDU Core Research (ECR) program offers this ECR:Core solicitation and invites proposals for fundamental research (curiosity-driven basic research and use-inspired basic research) that contributes to the general, explanatory knowledge that underlies STEM education in one or more of the three broadly conceived Research Areas: Research onSTEM Learning and Learning Environments, Research on Broadening Participation in STEM fields, andResearch on STEM Workforce Development. Within this framework, the ECR program supports a wide range of fundamental STEM education research activities, aimed at learners of all groups and ages in formal and informal settings. Fundamental researchgenerates knowledge and understanding with the potential for broad relevance. The potential implications of ECR fundamental research for improving STEM education practice may be indirect and long-term rather than direct and immediate. Moreover, whether they include basic or use-inspired basic research, all successf...
📅 Best viewed on desktop - or rotate your phone to landscape mode.
# Opportunity Type Region / Country Amount Deadline Source
37976 Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Eisen(III)natrium-Gluconat-Komplex (B03AC07) im Rahmen eines sogenannten Open-House-Modells. Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37977 Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Paliperidon (N05AX13) und dem Handelsnamen Trevicta® im Rahmen eines sogenannten Open-House-Modells. Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37978 Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Dienogest und Estrogen (G03FA15) im Rahmen eines sogenannten Open-House-Modells. Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37979 Czechia – Forestry services – TĚŽEBNÍ ČINNOST BEZ HARVESTOROVÉ TECHNOLOGIE 2024 Buyer: Vojenské lesy a statky ČR, s.p. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09... Tender Procurement Contract Czechia Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Vojenské lesy a statky ČR, s.p. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30

37980 Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-09 - Golimumab Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37981 Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-10 Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37982 Ireland – Financial management consultancy services – The Provision of Training Services for Local Enterprise Office Longford Buyer: Longford County Council_1128 | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-30 Tender Procurement Contract Ireland Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Longford County Council_1128 | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-30

37983 Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol (Wirkstoffkombination) Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37984 Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Febuxostat (ATC-Code nach WHO: M04AA03) Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37985 Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Fingolimod (ATC-Code nach WHO: L04AE01) Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37986 Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Telmisartan (ATC-Code nach WHO: C09CA07) Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37987 Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Latanoprost/Timolol (amtlicher ATC-Code: S01ED61) Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-30

37988 Austria – Electrical wiring and fitting work – Errichtung von 100 MWp Photovoltaikanlagen Buyer: Energie Steiermark Green Power GmbH | Notice type: cn-standard | Procedure: neg-w-call | Contract: works | Deadline: 2026-0... Tender Procurement Contract Austria Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Energie Steiermark Green Power GmbH | Notice type: cn-standard | Procedure: neg-w-call | Contract: works | Deadline: 2026-09-30

37989 Finland – Health services – Erikoislääkäripalvelut Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30 Tender Procurement Contract Finland Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30

37990 Finland – Health services – Erikoislääkäripalvelut Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30 Tender Procurement Contract Finland Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open TED / Tenders Electronic Daily
Source description

Buyer: Tuomi Logistiikka Oy | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-30

37991 Support European Food Bank Federation’s capacity building - 2026-2027 Support European Food Bank Federation’s capacity building - 2026-2027 Grant Cash Grant Europe Not provided on the source page. Please check the official source. Open Sep 30, 2026 Open EU Funding & Tenders Portal
Source description

Support European Food Bank Federation’s capacity building - 2026-2027

37992 Advanced Technological Education With a focus on two-year Institutions of Higher Education (IHEs), the Advanced Technological Education (ATE) program supports the... Grant Cash Grant United States Award range: $475,000 - $7,500,000 Open Oct 1, 2026 Open Grants.gov
Source description

With a focus on two-year Institutions of Higher Education (IHEs), the Advanced Technological Education (ATE) program supports the education of technicians for the high-technology fields that drive our nation's economy. The program involves partnerships between academic institutions (grades 7-12, IHEs), industry, and economic development agencies to promote improvement in the education of science and engineering technicians. It is strongly recommended that projects be faculty-led and required that courses and programs are credit-bearing, although materials developed may also be used for incumbent worker education. Materials may also be adapted and implemented as credit-bearing courses. The ATE program supports curriculum development; professional development of college faculty and secondary school teachers; career pathway development for both students and incumbent workers; and other activities including applied research projects that advance the knowledge base related to technician education. The ATE program encourages partnerships with other entities that may impact technician education. For example, with the National Institute of Standards and Technology (NIST) Manufacturing Extension Partnerships (MEPs) (http://www.nist.gov/mep/index.cfm) as applicable to support technician education programs and the industries they serve; and Manufacturing USA Institutes(https://manufacturing.gov/) addressing workforce development issues. The ATE program encourages proposals from Minority Serving Institutionsas well as other institutions that support the recruitment, retention, and comp...

37993 In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional) This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies... Grant Cash Grant United States Award ceiling: $500,000 Open Oct 1, 2026 Open Grants.gov
Source description

This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Both structural and functional aspects, including visualizing dynamic elements are important to development of new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Ultimately, research supported in response to this RFA is to encourage technologies that allow, for example, structures such as hair cells, otoliths, membranes, ions, and vasculature to be viewed in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multi-disciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans and intermediate studies in animals, but not non-mammalian species, may be proposed to develop or advance the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.

37994 Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required) This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and f... Grant Mixed United States Award ceiling: $500,000 Open Oct 1, 2026 Open Grants.gov
Source description

This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Structural and functional aspects, including visualizing dynamic elements, are important to developing new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Research supported in response to this RFA is expected to significantly advance the ability to visualize auditory and vestibular components, such as hair cells, otoliths, membranes, ions, and vasculature, in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multidisciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans must be proposed to develop,advance, or test the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.

37995 DoW, Ovarian Cancer, Investigator-Initiated Research Award Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact resea... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 1, 2026 Open Grants.gov
Source description

Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care.Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials.Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering project should significantly advance the research beyond what would be possible through individual efforts.

37996 DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing inten... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 1, 2026 Open Grants.gov
Source description

Summary: Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the OCA is to conduct innovative and impactful ovarian cancer research while developing successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.Distinctive Features: The OCA is a virtual career development and research training platform that consists of Early-Career Investigators (ECIs), their Designated Mentors, and an Academy Dean and Assistant Dean. The OCA-ECI Award is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, Mentors, the Dean and Assistant Dean) as well as with the advocacy community.

37997 DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investiga... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 1, 2026 Open Grants.gov
Source description

Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer.Distinctive Features: Research funded under this FY26 funding opportunity will support translational research and small-scale, early-phase clinical trials in ovarian cancer. Preliminary data are required, however, these data do not necessarily need to be derived from the ovarian cancer research field. The ECI must be within 12 years of their last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent at the time of full application submission deadline. The ECI must commit no less than 25% effort to this award and/or OCCTA activities for the first two years. The Designated Mentor must be a clinical trialist with a strong record of mentoring and training early-career investigators.

37998 DoW Ovarian Cancer, Clinical Trial Award Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significa... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 1, 2026 Open Grants.gov
Source description

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

37999 DoW, Ovarian Cancer, Pilot Award Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ova... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Oct 1, 2026 Open Grants.gov
Source description

Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward.Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism.This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a collaborator, or the organization of the PI or collaborator.

38000 EDU Core Research The EDU Core Research (ECR) program offers this ECR:Core solicitation and invites proposals for fundamental research (curiosity-dr... Grant Cash Grant United States Award range: $500,000 - $2,500,000 Open Oct 1, 2026 Open Grants.gov
Source description

The EDU Core Research (ECR) program offers this ECR:Core solicitation and invites proposals for fundamental research (curiosity-driven basic research and use-inspired basic research) that contributes to the general, explanatory knowledge that underlies STEM education in one or more of the three broadly conceived Research Areas: Research onSTEM Learning and Learning Environments, Research on Broadening Participation in STEM fields, andResearch on STEM Workforce Development. Within this framework, the ECR program supports a wide range of fundamental STEM education research activities, aimed at learners of all groups and ages in formal and informal settings. Fundamental researchgenerates knowledge and understanding with the potential for broad relevance. The potential implications of ECR fundamental research for improving STEM education practice may be indirect and long-term rather than direct and immediate. Moreover, whether they include basic or use-inspired basic research, all successful ECR:Core proposals focus on the advancement or refinement of foundational knowledge for STEM education. The amount of funding and duration requested in proposals submitted to the ECR:Core solicitation should align with the maturity of the proposed work and the size and scope of the empirical effort. The solicitation has three levels of funding with a range of budget sizes, and proposals may request a duration of 3 to 5 years for any level: (1)Level I proposals may request up to $500,000; (2)Level II proposals may request up to $1,500,000; (3)Level III proposalsmay request up to $2,500,000.....